BlueCrest Capital Management’s Qiagen QGEN Stock Holding History

BlueCrest Capital Management’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,793	Closed	-$321K	–	1335
2018 Q4	$321K	Buy	+8,793	New	+$327K	0.02%	481
2018 Q2	–	Sell	-8,840	Closed	-$303K	–	1751
2018 Q1	$303K	Buy	+8,840	New	+$310K	0.01%	1049
2017 Q3	–	Sell	-45,266	Closed	-$1.61M	–	1047
2017 Q2	$1.61M	Sell	45,266 -79,908	-64%	-$2.7M	0.06%	376
2017 Q1	$3.85M	Buy	+125,174	New	+$3.86M	0.18%	155

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlueCrest Capital Management's QGEN Position: Q1 2019 in Review

BlueCrest Capital Management sold out of Qiagen (QGEN) in Q1 2019, closing a stake of 8,793 shares — an estimated $321K sold.

BlueCrest Capital Management first reported a position in QGEN in Q1 2017 and held it in 4 quarters. The position peaked at $3.85M in Q1 2017. 261 funds tracked by Wall St. Rank hold QGEN as of Q1 2019.

BlueCrest Capital Management reported no remaining Qiagen position as of Q1 2019 after selling out during the quarter.
BlueCrest Capital Management sold 8,793 Qiagen shares in Q1 2019, an estimated $321K.
BlueCrest Capital Management first reported a position in Qiagen in Q1 2017 and held it in 4 quarters.
BlueCrest Capital Management's Qiagen position peaked at $3.85M in Q1 2017.
261 funds tracked by Wall St. Rank held Qiagen as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.